123 related articles for article (PubMed ID: 8887296)
1. IL-1 beta, a major stimulator of hyaluronan synthesis in vitro of human peritoneal mesothelial cells: relevance to peritonitis in CAPD.
Yung S; Coles GA; Davies M
Kidney Int; 1996 Oct; 50(4):1337-43. PubMed ID: 8887296
[TBL] [Abstract][Full Text] [Related]
2. Role of peritoneal mesothelial cells and fibroblasts in the synthesis of hyaluronan during peritoneal dialysis.
Breborowicz A; Wisniewska J; Polubinska A; Wieczorowska-Tobis K; Martis L; Oreopoulos DG
Perit Dial Int; 1998; 18(4):382-6. PubMed ID: 10505559
[TBL] [Abstract][Full Text] [Related]
3. Increased production of hyaluronan by peritoneal cells and its significance in patients on CAPD.
Lai KN; Szeto CC; Lai KB; Lam CW; Chan DT; Leung JC
Am J Kidney Dis; 1999 Feb; 33(2):318-24. PubMed ID: 10023645
[TBL] [Abstract][Full Text] [Related]
4. Superinduction of IL-6 synthesis in human peritoneal mesothelial cells is related to the induction and stabilization of IL-6 mRNA.
Witowski J; Jörres A; Coles GA; Williams JD; Topley N
Kidney Int; 1996 Oct; 50(4):1212-23. PubMed ID: 8887280
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of hyaluronic acid by human peritoneal mesothelial cells: effect of cytokines and dialysate.
Breborowicz A; Korybalska K; Grzybowski A; Wieczorowska-Tobis K; Martis L; Oreopoulos DG
Perit Dial Int; 1996; 16(4):374-8. PubMed ID: 8863330
[TBL] [Abstract][Full Text] [Related]
6. The source and possible significance of hyaluronan in the peritoneal cavity.
Yung S; Coles GA; Williams JD; Davies M
Kidney Int; 1994 Aug; 46(2):527-33. PubMed ID: 7967367
[TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal nitric oxide production in patients treated by continuous ambulatory peritonal dialysis.
Davenport A; Fernando RL; Varghese Z
Blood Purif; 2004; 22(2):216-23. PubMed ID: 15044821
[TBL] [Abstract][Full Text] [Related]
8. Human peritoneal fibroblast proliferation in 3-dimensional culture: modulation by cytokines, growth factors and peritoneal dialysis effluent.
Beavis MJ; Williams JD; Hoppe J; Topley N
Kidney Int; 1997 Jan; 51(1):205-15. PubMed ID: 8995735
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis.
Brauner A; Hylander B; Wretlind B
Am J Kidney Dis; 1996 Mar; 27(3):402-8. PubMed ID: 8604710
[TBL] [Abstract][Full Text] [Related]
10. High glucose solution and spent dialysate stimulate the synthesis of transforming growth factor-beta1 of human peritoneal mesothelial cells: effect of cytokine costimulation.
Kang DH; Hong YS; Lim HJ; Choi JH; Han DS; Yoon KI
Perit Dial Int; 1999; 19(3):221-30. PubMed ID: 10433158
[TBL] [Abstract][Full Text] [Related]
11. Human peritoneal mesothelial cell prostaglandin synthesis: induction of cyclooxygenase mRNA by peritoneal macrophage-derived cytokines.
Topley N; Petersen MM; Mackenzie R; Neubauer A; Stylianou E; Kaever V; Davies M; Coles GA; Jörres A; Williams JD
Kidney Int; 1994 Sep; 46(3):900-9. PubMed ID: 7996812
[TBL] [Abstract][Full Text] [Related]
12. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis.
Lai KN; Lai KB; Lam CW; Chan TM; Li FK; Leung JC
Am J Kidney Dis; 2000 Apr; 35(4):644-52. PubMed ID: 10739785
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
[TBL] [Abstract][Full Text] [Related]
14. Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD.
Pannekeet MM; Zemel D; Koomen GC; Struijk DG; Krediet RT
Perit Dial Int; 1995; 15(6):217-25. PubMed ID: 7578497
[TBL] [Abstract][Full Text] [Related]
15. The effect of N-acetylglucosamine as a substrate for in vitro synthesis of glycosaminoglycans by human peritoneal mesothelial cells and fibroblasts.
Breborowicz A; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Wisniewska J; Tam P; French I; Wu G
Adv Perit Dial; 1998; 14():31-5. PubMed ID: 10649686
[TBL] [Abstract][Full Text] [Related]
16. Increased survival of mesothelial cells from the peritoneum in peritoneal dialysis fluid.
Lai KN; Ho SK; Leung J; Tang SC; Chan TM; Li FK
Cell Biol Int; 2001; 25(5):445-50. PubMed ID: 11401332
[TBL] [Abstract][Full Text] [Related]
17. Human peritoneal mesothelial cells synthesize IL-1 alpha and beta.
Douvdevani A; Rapoport J; Konforty A; Argov S; Ovnat A; Chaimovitz C
Kidney Int; 1994 Oct; 46(4):993-1001. PubMed ID: 7861725
[TBL] [Abstract][Full Text] [Related]
18. Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions.
Stadlmann S; Amberger A; Pollheimer J; Gastl G; Offner FA; Margreiter R; Zeimet AG
Gynecol Oncol; 2005 Jun; 97(3):784-9. PubMed ID: 15943987
[TBL] [Abstract][Full Text] [Related]
19. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis.
Zemel D; Koomen GC; Hart AA; ten Berge IJ; Struijk DG; Krediet RT
J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688
[TBL] [Abstract][Full Text] [Related]
20. Inverse MCP-1/IL-8 ratio in effluents of CAPD patients with peritonitis and in isolated cultured human peritoneal macrophages.
Sach M; Bauermeister K; Burger JA; Loetscher P; Elsner J; Schollmeyer P; Dobos GJ
Nephrol Dial Transplant; 1997 Feb; 12(2):315-20. PubMed ID: 9132652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
